Pharsight

Drugs that contain Pasireotide Diaspartate

1. Signifor patents expiration

Can you believe SIGNIFOR received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8299209 RECORDATI RARE Pharmaceutical composition comprising cyclic somatostatin analogues
Dec, 2025

(1 year, 10 months from now)

US7473761 RECORDATI RARE Somatostatin analogues
Dec, 2026

(2 years from now)

Market Authorisation Date: 14 December, 2012

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

SIGNIFOR family patents

Family Patents